Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Express Scripts
Boehringer Ingelheim
Harvard Business School
Baxter

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHYLNALTREXONE BROMIDE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for METHYLNALTREXONE BROMIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00401375 ↗ Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 2006-10-31 To evaluate the safety and efficacy of MNTX in participants who have undergone segmental colectomy and to assess if the time between the end of surgery and the first bowel movement is significantly shorter in the MNTX regimen than the equivalent assessment using a placebo regimen.
NCT00401375 ↗ Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) Completed Bausch Health Americas, Inc. Phase 3 2006-10-31 To evaluate the safety and efficacy of MNTX in participants who have undergone segmental colectomy and to assess if the time between the end of surgery and the first bowel movement is significantly shorter in the MNTX regimen than the equivalent assessment using a placebo regimen.
NCT00401375 ↗ Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) Completed Valeant Pharmaceuticals International, Inc. Phase 3 2006-10-31 To evaluate the safety and efficacy of MNTX in participants who have undergone segmental colectomy and to assess if the time between the end of surgery and the first bowel movement is significantly shorter in the MNTX regimen than the equivalent assessment using a placebo regimen.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for METHYLNALTREXONE BROMIDE

Condition Name

Condition Name for METHYLNALTREXONE BROMIDE
Intervention Trials
Opioid-induced Constipation 5
Constipation 4
Pancreatic Cancer 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for METHYLNALTREXONE BROMIDE
Intervention Trials
Constipation 9
Opioid-Induced Constipation 7
Pancreatic Neoplasms 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for METHYLNALTREXONE BROMIDE

Trials by Country

Trials by Country for METHYLNALTREXONE BROMIDE
Location Trials
United States 84
Canada 17
Australia 5
Spain 3
Korea, Republic of 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for METHYLNALTREXONE BROMIDE
Location Trials
North Carolina 5
New York 5
Ohio 4
Florida 4
California 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for METHYLNALTREXONE BROMIDE

Clinical Trial Phase

Clinical Trial Phase for METHYLNALTREXONE BROMIDE
Clinical Trial Phase Trials
Phase 4 3
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for METHYLNALTREXONE BROMIDE
Clinical Trial Phase Trials
Completed 13
Withdrawn 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METHYLNALTREXONE BROMIDE

Sponsor Name

Sponsor Name for METHYLNALTREXONE BROMIDE
Sponsor Trials
Bausch Health Americas, Inc. 12
Valeant Pharmaceuticals International, Inc. 10
Progenics Pharmaceuticals, Inc. 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for METHYLNALTREXONE BROMIDE
Sponsor Trials
Industry 30
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Moodys
Boehringer Ingelheim
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.